This double-blind study of 20 patients with obsessive-compulsive disorder (OCD) tests the hypothesis that; 1) Intravenous pulse loading of clomipramine (150 mg Day 1, 200 mg Day 2) will produce a larger decrease in symptoms of OCD than will identical oral doses; and 2) the larger the drop in core body temperature produced by the first dose of clomipramine, the more likely the patient's OCD symptoms will respond.
Showing the most recent 10 out of 589 publications